|
1
|
|
HIF-1-mediated PPME1 expression promotes breast cancer progression via AKT activation and beta-catenin recruitment.
(jci.org)
|
Lyu Y
…
Semenza GL
Journal of Clinical Investigation
2026-10-01
|
#breast cancer
#hypoxia
#immunotherapy
#signaling
#stemness
|
|
1
|
|
Antibody-drug conjugates in breast cancer: redefining targeted therapy.
(jci.org)
|
Guo C
…
Ellisen LW
Journal of Clinical Investigation
2026-10-01
|
#breast cancer
#immunotherapy
#drug delivery
#amr
#biomarker
|
|
3
|
|
Giredestrant plus Everolimus in Advanced Breast Cancer.
(nejm.org)
|
Mayer EL
…
Rugo HS
New England Journal of Medicine
2026-10-01
|
#breast cancer
#clinical trial
#endocrine therapy
#estrogen receptor
#drug resistance
|
|
1
|
|
Expanding the therapeutic scope of PARP inhibitors in breast cancer: current indications and future directions.
(jci.org)
|
Walmsley CS
…
Lynce F
Journal of Clinical Investigation
2026-10-01
|
#breast cancer
#parp-inhibitors
#homologous recombination
#synthetic lethality
#biomarker
|
|
1
|
|
Breast cancer immunogenicity as a spectrum: evolving concepts and therapeutic implications.
(jci.org)
|
Kay J
…
Loi S
Journal of Clinical Investigation
2026-10-01
|
#immunotherapy
#immunogenicity
#breast cancer
#immunity
#tumors
|